# Outram Bio

Outram Bio is a Private Equity based in Singapore, Singapore.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Singapore, Singapore
- **Region:** Asia
- **Address:** Singapore
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** www.outrambio.com
- **LinkedIn:** https://www.linkedin.com/company/outram-bio

## Regulatory record

- **Reports private funds:** No

## About

Outram Bio is an investment company based in Singapore. Founded in 2021, it focuses on investments in Asia. Outram Bio has made one investment, in Albatroz Therapeutics, as part of a Seed VC round on April 25, 2023.

## Questions

### What is Outram Bio's core investment focus?

Outram Bio targets early-stage life sciences and biotechnology companies, primarily at the startup and Series A stages. The firm's mandate covers drug discovery, platform technologies, and therapeutic development. This singular focus on biotech distinguishes it from generalist technology and healthcare funds active in Asia.

### Which sectors does Outram Bio explicitly avoid?

Outram Bio's mandate is narrowly focused on biotechnology and life sciences. Public information does not indicate the firm evaluates opportunities in consumer technology, fintech, enterprise software, real estate, or other non-healthcare verticals. Its exclusion profile is driven by sector concentration rather than an explicit avoidance list.

## Related profiles

- [Outpost Ventures](https://altss.com/profile/outpost-ventures)
- [Outrunner Capital](https://altss.com/profile/outrunner-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/outram-bio

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology